Roberto Bueno Filho

Roberto Bueno Filho

Auto-generated profile, based on publicly available information

Roberto Bueno Filho

Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto, Brazil

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2024 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PCPaulo Criado
Paulo Criado
HMHelio Miot
Helio Miot
RBRoberto Bueno-Filho
Roberto Bueno-Filho
MIMayra Ianhez
Mayra Ianhez
RCRoberta Fachini Jardim Criado
Roberta Fachini Jardim Criado
CCCaio César Silva de Castro
Caio César Silva de Castro
Atopic dermatitis is a chronic, recurrent, and multifactorial skin-mucosal manifestation resulting from the interaction between elements mainly associated with the skin barrier deficit, the homeostasis of the immune response, neurological aspects, and patterns of reactivity to environmental antigens, which are established in genetically predisposed individuals. In addition to the skin, atopic diathesis involves other organs such as the airways (upper and lower), eyes, digestive tract, and neuropsychiatric aspects, which inflict additional morbidity on the dermatological patient. The different phenotypes of the disease fundamentally depend on the participation of each of these factors, in different life circumstances, such as age groups, occupational exposure patterns, physical activity, pollution, genetic load, and climatic factors. A better understanding of the complexity of its pathogenesis allows not only the understanding of therapeutic targets but also how to identify preponderant elements that mediate disease activity in each circumstance, for selecting the best treatment strategies and mitigation of triggering factors. This narrative review presents an update on the pathogenesis of atopic dermatitis, especially aimed at understanding the clinical manifestations, the main disease phenotypes and the context of available therapeutic strategies.

1 November 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
LALuciana Patricia Fernandes Abbade
Luciana Patricia Fernandes Abbade
MFMaria Lucia Frade
Maria Lucia Frade
JPJosé Roberto Pereira Pegas
José Roberto Pereira Pegas
PDPaula Dadalti-Granja
Paula Dadalti-Granja
LGLucas Campos Garcia
Lucas Campos Garcia
CPCarlos Eduardo Fonseca Parenti
Carlos Eduardo Fonseca Parenti
Chronic leg ulcers affect a large portion of the adult population and cause a significant social and economic impact, related to outpatient and hospital care, absence from work, social security expenses, and reduced quality of life. The correct diagnosis and therapeutic approach are essential for a favorable evolution. To gather the experience of Brazilian dermatologists, reviewing the specialized literature to prepare recommendations for the diagnosis and treatment of the main types of chronic leg ulcers. Seven specialists from six university centers with experience in chronic leg ulcers were appointed by the Brazilian Society of Dermatology to reach a consensus on the diagnosis and therapeutic management of these ulcers. Based on the adapted DELPHI methodology, relevant elements were considered in the diagnosis and treatment of chronic leg ulcers of the most common causes; then, the recent literature was analyzed using the best scientific evidence. The following themes were defined as relevant for this consensus - the most prevalent differential etiological diagnoses of chronic leg ulcers (venous, arterial, neuropathic, and hypertensive ulcers), as well as the management of each one. It also included the topic of general principles for local management, common to chronic ulcers, regardless of the etiology. This consensus addressed the main etiologies of chronic leg ulcers and their management based on scientific evidence to assist dermatologists and other health professionals and benefit the greatest number of patients with this condition.

1 February 2019 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
CWCarlos Gustavo Wambier
Carlos Gustavo Wambier
THThaís Angélica Hoekstra
Thaís Angélica Hoekstra
SWSarah Perillo de Farias Wambier
Sarah Perillo de Farias Wambier
RFRoberto Bueno Filho
Roberto Bueno Filho
FVFernando Crivelenti Vilar
Fernando Crivelenti Vilar
NFNorma Tiraboschi Foss
Norma Tiraboschi Foss
Keywords: Acquired immunodeficiency syndrome; Epidermal necrolysis, toxic; Hospitalization; Length of stay; Lethality; Scales; Stevens-Johnson syndrome

22 May 2023 in Inflammation Research
Verified
Journal Article
Open access
PDF file
PCPaulo Criado
Paulo Criado
DLDaniel Lorenzini
Daniel Lorenzini
HMHelio Miot
Helio Miot
RBRoberto Bueno-Filho
Roberto Bueno-Filho
FCFrancisca Regina Oliveira Carneiro
Francisca Regina Oliveira Carneiro
MIMayra Ianhez
Mayra Ianhez
Objective and design The discovery of new inflammatory pathways and the mechanism of action of inflammatory, autoimmune, genetic, and neoplastic diseases led to the development of immunologically driven drugs. We aimed to perform a narrative review regarding the rising of a new class of drugs capable of blocking important and specific intracellular signals in the maintenance of these pathologies: the small molecules. Materials/methods A total of 114 scientific papers were enrolled in this narrative review. Results We describe in detail the families of protein kinases—Janus Kinase (JAK), Src kinase, Syk tyrosine kinase, Mitogen-Activated Protein Kinase (MAPK), and Bruton Tyrosine Kinase (BTK)—their physiologic function and new drugs that block these pathways of intracellular signaling. We also detail the involved cytokines and the main metabolic and clinical implications of these new medications in the field of dermatology. Conclusions Despite having lower specificity compared to specific immunobiological therapies, these new drugs are effective in a wide variety of dermatological diseases, especially diseases that had few therapeutic options, such as psoriasis, psoriatic arthritis, atopic dermatitis, alopecia areata, and vitiligo.

1 January 2012 in Clinics
Verified
Journal Article
Open access
RFRoberto Bueno Filho
Roberto Bueno Filho
ACAlberto Pinto Cordeiro
Alberto Pinto Cordeiro
FAFlavia Tremeschin de Almeida
Flavia Tremeschin de Almeida
CSCatarina Shaletich
Catarina Shaletich
RCRoberto Silva Costa
Roberto Silva Costa
ARAna Maria Roselino
Ana Maria Roselino

1 February 2018 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PDF file
SVSebastian Vernal
Sebastian Vernal
MBMaria Jose Franco Brochado
Maria Jose Franco Brochado
RBRoberto Bueno-Filho
Roberto Bueno-Filho
PLPaulo Louzada-Junior
Paulo Louzada-Junior
ARAna Maria Roselino
Ana Maria Roselino
Keywords: Leprosy; Antiphospholipid antibodies; Beta-2-glycoprotein-I; Factor V Leiden; Prothrombin; Thromboembolism